BNGRF Stock Chart & Stats
$74.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$52.30 - $89.10
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$901.10M
Enterprise Value$2.09K
Total Cash (Recent Filing)$684.84M
Total Debt (Recent Filing)$1.24B
Price to Earnings (P/E)10.2
Beta0.32
Next Earnings
Mar 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.29%
Share Statistics
EPS (TTM)5.73
Shares Outstanding14,032,930
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.52
Price to Sales (P/S)0.13
P/FCF Ratio14.73
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.11
Revenue Forecast (FY)$8.95B
Bulls Say, Bears Say
Bulls Say
Diversified Dairy Portfolio And ChannelsSavencia’s combination of branded consumer products and specialty dairy offerings gives it multiple routes to market and demand sources. International retail and foodservice exposure can support resilience, while product breadth may help preserve relevance across customer needs and categories over the next several quarters.
Long-term Revenue ScaleThe multi-year revenue increase through 2024 indicates that Savencia has maintained substantial operating scale and underlying market presence. Although the latest year weakened, the established revenue base and history of expansion provide a platform for recovery if demand and pricing conditions improve.
Manageable LeverageLeverage appears contained for a packaged-foods company, with debt-to-equity broadly stable and equity preserved over time. This balance-sheet position should provide more flexibility than a highly leveraged structure to manage operating volatility, support investment, and address obligations over the medium term.
Bears Say
2025 Revenue ContractionThe reversal from multi-year revenue growth to a 2.8% decline signals weaker recent demand, pricing, mix, or volume performance. A sustained contraction would reduce operating leverage and make it harder for Savencia to spread fixed costs, defend market position, and rebuild earnings over coming quarters.
Compressed Operating MarginsMargin compression indicates that recent revenue performance is not translating efficiently into operating profit. With net margin already very thin, further cost pressure or limited pricing recovery could disproportionately reduce earnings, constrain reinvestment, and weaken the company’s cushion against business volatility.
Weak Cash ConversionWeak conversion of reported profit into free cash flow reduces internally generated financial flexibility. This leaves less cash available for debt reduction, dividends, or reinvestment and makes the quality of earnings more dependent on an eventual improvement in working-capital and operating cash generation.
Savencia News
BNGRF FAQ
What was Savencia SA’s price range in the past 12 months?
Savencia SA lowest stock price was $52.30 and its highest was $89.10 in the past 12 months.
What is Savencia SA’s market cap?
Savencia SA’s market cap is $901.10M.
When is Savencia SA’s upcoming earnings report date?
Savencia SA’s upcoming earnings report date is Mar 11, 2027 which is in 173 days.
How were Savencia SA’s earnings last quarter?
Savencia SA released its earnings results on Sep 10, 2026. The company reported $3.338 earnings per share for the quarter.
Is Savencia SA overvalued?
According to Wall Street analysts Savencia SA’s price is currently Undervalued.
Does Savencia SA pay dividends?
Savencia SA pays a Annually dividend of $1.624 which represents an annual dividend yield of 2.29%. See more information on Savencia SA dividends here
What is Savencia SA’s EPS estimate?
Savencia SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Savencia SA have?
Savencia SA has 14,032,930 shares outstanding.
What happened to Savencia SA’s price movement after its last earnings report?
Savencia SA reported an EPS of $3.338 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Savencia SA?
Currently, no hedge funds are holding shares in BNGRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Savencia SA
Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.
Technical Analysis
Ownership Overview
―
Insiders
1.10% Mutual Funds
― Other Institutional Investors
98.86% Public Companies and
Individual Investors